New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors
OncoMed Pharmaceuticals, Inc., a privately held, clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor initiating cells, today highlighted new data...
View ArticleScientists identify novel mechanism behind bacterial pathogenesis
Scientists have identified a new mechanism of bacterial pathogenesis. The results of the research project, partly funded by the Academy of Finland, have been published in the journal Proceedings of the...
View ArticleCBIS initiates CS-TATI-1 GMP development plan
Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical to meet global public health challenges is pleased to announce the initiation of GMP development plan for CS-TATI-1...
View ArticleCannabis Science commences CSTATI-1 preclinical studies in Squamous/BCCs,...
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe...
View ArticleGalectin-1 drives growth of Kaposi sarcoma tumors
A sugar-loving protein drives the growth of Kaposi sarcoma (KS) tumors, according to a study published on October 1st in The Journal of Experimental Medicine. Interfering with these sugary interactions...
View ArticleBurkitt lymphoma risk after transplantation highlighted
Solid organ transplant recipients have a significant risk for developing Burkitt lymphoma (BL), US researchers have found.
View ArticleTousled-like kinases play a key role in suppression and activation of...
Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) hide within the worldwide human population. While dormant in the vast majority of those infected, these active herpesviruses...
View ArticleKaposi’s sarcoma risk factors revealed
Scientists have uncovered an intriguing relationship between the risk for Kaposi’s sarcoma, smoking, and the use of highly active antiretroviral therapy.
View ArticleNew plug-in optical sensor can help diagnose Kaposi's sarcoma
As antiretroviral drugs that treat HIV have become more commonplace, the incidence of Kaposi's sarcoma, a type of cancer linked to AIDS, has decreased in the United States.
View ArticleResearchers discover promising new way to treat HIV-related blood cancer
Researchers at the USC Norris Comprehensive Cancer Center have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV.
View ArticleStudy reports racial, ethnic differences in incidence of soft tissue sarcomas...
Mei-Chin Hsieh, MSPH, CTR, of LSU Health Sciences Center New Orleans School of Public Health's Louisiana Tumor Registry, is the lead author of a study that reports racial and ethnic differences in the...
View ArticleApoptosis can reactivate latent herpesviruses in dying cell
Researchers have found that apoptosis, a natural process of programmed cell death, can reactivate latent herpesviruses in the dying cell. The results of their research, which could have broad clinical...
View ArticleNIH program provides $22M for low- and middle-income countries to combat...
A new NIH program supporting HIV-related research training will provide $22 million over five years for activities in 15 low- and middle-income countries. The Fogarty International Center's HIV...
View ArticleEvidence shows vaccination pilot campaigns highly successful during 2010...
The deadly cholera epidemic that rocked earthquake-shattered Haiti in 2010, claiming 8,000 lives and counting, has rallied the public health community to seek water and sewer improvements that,...
View ArticleCytrx announces Q3 2013 financial results, provides clinical update
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three and nine-month periods ended September 30, 2013, and...
View ArticleJanssen reports positive pivotal Phase 2 study data of siltuximab for...
Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best...
View ArticleResearch reveals new therapy for preventing production of sphingolipids by...
Christopher Parsons, MD, Director of the HIV Malignancies Program at LSU Health Sciences Center New Orleans, is the senior author of a paper that is the first to report that specialized fat (lipid)...
View ArticleCytRx receives FDA approval to continue dosing aldoxorubicin for patients...
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has received approval from the U.S. Food and Drug Administration (FDA)...
View ArticleCytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with...
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a Phase 2 clinical trial to determine preliminary efficacy and safety...
View ArticleScientists identify twenty proteins specifically secreted by primary effusion...
Primary effusion lymphoma (PEL) is a rare B-cell neoplasm distinguished by its tendency to spread along the thin serous membranes that line body cavities without infiltrating or destroying nearby tissue.
View Article
